| Autor: |
Thakur, S. S., Patel, Priya, sukheja, Chakshu, Manzoor, Mohammad Wasif, Kumar, Sunil, Mittal, Meena, Panchonia, Ashok |
| Předmět: |
|
| Zdroj: |
Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research); 2024, Vol. 15 Issue 7, p2106-2127, 22p |
| Abstrakt: |
Fungiuria or in simple way Fungal urinary tract infection (UTI) represents a common cause for urinary tract infection in paediatric age group. Since few years, increasing incidence is associated with long and high dose use of broad-spectrum antibiotics, steroids, immunosuppressive and cytotoxic drugs. Other contributing factors include congenital structural or functional abnormalities of urinary tract with indwelling urinary catheter .Since the pandemic of SARS-CoV-2, a significant rise in threatening fungal co-infections in COVID-19 patients has been testified in the scientific literature. all urine sample submitted in OPD and IPD of symptomatic patients with funguria of >104-5 CFU/ml and leucocyturia were analysed for etiology, risk factors and outcome. Candida albicans was isolated in maximum number of paediatric population and non-Candida yeasts (aspergillous species)observed in few cases. Based on microscopic fungal hyphae score and clinical symptoms,they were treated with systemic antifungals. Systemic antifungal therapy should be considered in high-risk patients with age group 1-4yr along with high fungal score (FH++++). [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
